1xbet 한국 Pharmaceutical Co., Ltd.
Pharmaceuticals
March 12, 2010
FerriSeltz®powder 20%, MRI Oral GI Contrast Agent, Receives Additional Approval 1xbet 한국 GI Negative Imaging in Cholangiopancreatography
1xbet 한국 Pharmaceutical Co., Ltd. (Head Office: Chiyoda-ku, Tokyo, Japan; President: Taro Iwamoto) today announced that it acquired additional approval of indications, dosage and administration for the MRI oral GI contrast agent, FerriSeltz®powder 20%, 1xbet 한국 GI negative imaging in cholangiopancreatography in abdominal magnetic resonance and computed tomography on March 12, 2010.
Latest Pharmaceutical Bus1xbet 한국ess related News Releases